Articles for Immupharma (LSE: IMM)

Top shares for March

We asked our analysts to share their top stock picks for the month. More »

2 more pharma stocks that could make you a fortune

Royston Wild looks at another couple of pharma fizzers that could make you rich. More »

This promising small-cap stock could be a millionaire maker in 2018

For those willing to take the risk, Paul Summers thinks there could be substantial upside ahead for backers of this small-cap stock. More »

These stellar small-cap stocks could be good for your wealth

Despite the risks involved, Paul Summers thinks these two small-cap stocks still offer a lot of upside. More »

Why I’d still buy this growth stock even after today’s 20% spike

These two smaller companies are flying high today as investors seek to take advantage of recent strong results, says Harvey Jones. More »

AstraZeneca plc isn’t the only pharma star that could make you rich

AstraZeneca plc (LON: AZN) isn't the only pharma giant that could make you rich. Here Royston Wild looks at another drugs star with brilliant... More »

2 dangerous stocks I’d consider selling today

Roland Head highlights some potentially serious risks you may be overlooking. More »

Why are Immupharma plc, Purplebricks Group plc and Roxi Petroleum plc among today’s major movers?

Should you buy or sell these 3 big movers? Immupharma plc (LON: IMM), Purplebricks Group plc (LON: PURP) and Roxi Petroleum plc (LON: RXP) More »

Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?

Should you invest in juniors Synairgen plc (LON:SNG) and Immupharma plc (LON:IMM) or giant AstraZeneca plc (LON:AZN)? More »

Should You Buy KAZ Minerals PLC & ImmuPharma PLC On Tuesday?

Royston Wild examines the investment case for KAZ Minerals PLC (LON: KAZ) and ImmuPharma PLC (LON: IMM). More »